Orion predicted strong growth for darolutamide, the prescription prostate-cancer medication it co-developed with Bayer.

Bayer AG’s pharmaceuticals unit is on track for a return to growth as new drugs for cancer and kidney disease offset sales ...

The Bayer Pharma AG logo is seen on April 03, 2025 in Berlin, Germany. This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma ...

To promote its newly launched nonhormonal menopause drug, Bayer is linking Lynkuet with a familiar face. The Big Pharma has recruited Gabrielle Union-Wade to serve as a celebrity endorser for the ...

In early January 2026, Bayer’s subsidiaries and partners reported a series of R&D advances, including FDA acceptance of ...

The collaboration builds on the internal strengths of Bayer in antibody design, synthesis and machine learning, complementing ...

Werner Baumann, CEO of Leverkusen, Germany-based Bayer, on Wednesday shared his thoughts on rising drug costs, his company’s own drug pricing system and President Donald Trump in an interview with ...

Aliqopa is intended to treat adults with relapsed follicular lymphoma who have received at least two previous therapies for the disease. Follicular lymphoma is a slow-growing form of non-Hodgkin ...

The U.S. Food And Drug Administration (FDA) granted full approval to Bayer AG’s (OTC:BAYRY) Vitrakvi (larotrectinib) for adult and pediatric patients with solid tumors that have a neurotrophic ...

Bayer stock jumped on Monday after the German healthcare company said a late-stage stroke drug trial achieved its goals. Bayer didn’t give too much away: on Sunday the company said a Phase III trial ...

The logo of Bayer Mexico is pictured at the company's plant in Lerma, Mexico November 10, 2022. REUTERS/Henry Romero (Reuters) -Germany's Bayer said on Friday the U.S. health regulator has approved ...